You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 18, 2024

CLINICAL TRIALS PROFILE FOR MIROGABALIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Mirogabalin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02146430 ↗	Treatment of Pain Associated With Fibromyalgia	Completed	INC Research	Phase 3	The main objective of this trial is to compare change in weekly average daily pain score (ADPS) from baseline to Week 13 in subjects receiving either dose of DS-5565 versus placebo. Weekly ADPS is based on daily pain scores reported by the participant that best describes his or her worst pain over the previous 24 hours.
NCT02146430 ↗	Treatment of Pain Associated With Fibromyalgia	Completed	Syneos Health	Phase 3	The main objective of this trial is to compare change in weekly average daily pain score (ADPS) from baseline to Week 13 in subjects receiving either dose of DS-5565 versus placebo. Weekly ADPS is based on daily pain scores reported by the participant that best describes his or her worst pain over the previous 24 hours.
NCT02146430 ↗	Treatment of Pain Associated With Fibromyalgia	Completed	Daiichi Sankyo Inc.	Phase 3	The main objective of this trial is to compare change in weekly average daily pain score (ADPS) from baseline to Week 13 in subjects receiving either dose of DS-5565 versus placebo. Weekly ADPS is based on daily pain scores reported by the participant that best describes his or her worst pain over the previous 24 hours.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Mirogabalin

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Diabetic Peripheral Neuropathic Pain	3
Pain Associated With Fibromyalgia	3
Post-Herpetic Neuralgia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Neuralgia	5
Myofascial Pain Syndromes	4
Fibromyalgia	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Mirogabalin

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United States	106
United Kingdom	15
Canada	7
Australia	5
India	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for
Location	Trials
Michigan	4
California	4
Arizona	4
Washington	4
Texas	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Mirogabalin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	8
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	8
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mirogabalin

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Daiichi Sankyo Co., Ltd.	5
INC Research	4
Syneos Health	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	18
Other	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.